Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Rosetta Capital is a UK-based venture capital firm that specializes in the life sciences and medical device sectors. Founded over 20 years ago, the firm has established a strong presence in the global investment landscape, particularly in North America and Europe. Rosetta Capital has executed numerous transactions, focusing on transforming healthcare through strategic investments.
The firm currently manages over 50 venture investments, showcasing its extensive experience in navigating complex transactions. With a dedicated team operating from offices in Oxford and London, Rosetta Capital is well-positioned to support innovative companies in the healthcare sector.
Rosetta Capital invests primarily in the life sciences and medical device sectors, targeting seed, Series A, Series B, and growth equity stages. The firm employs a global investment strategy, focusing on opportunities in North America and Europe. Rosetta Capital utilizes direct secondary transactions to provide flexible liquidity solutions to investors and corporations, which allows for tailored investment approaches.
In addition to capital, Rosetta Capital actively supports its portfolio companies through follow-on financings and strategic engagement with management teams and boards. This hands-on approach ensures that the firms they invest in receive the necessary resources and guidance to thrive in the competitive healthcare market.
Rosetta Capital's portfolio includes a mix of notable companies, both exited and private. Key portfolio companies are:
This diverse portfolio reflects Rosetta Capital's commitment to investing in transformative healthcare solutions.
Jonathan Hepple - Managing Partner. Hepple has extensive experience in venture capital and has led numerous successful investments in the life sciences sector.
Ken MacLeod - Partner. MacLeod brings a wealth of knowledge in healthcare investments and has been instrumental in guiding portfolio companies.
Michael Forer - Partner. Forer has a strong background in managing complex transactions and supporting growth-stage companies.
Matthew James - Chief Financial Officer. James oversees financial operations and strategy, ensuring the firm’s fiscal health.
Donovan Leung - Investment Manager. Leung focuses on sourcing and evaluating new investment opportunities in the life sciences.
Melissa Riachi - Investment Analyst. Riachi supports the investment team with research and analysis of potential portfolio companies.
To pitch Rosetta Capital, founders should email info@rosettacapital.com with a detailed pitch deck. The deck should include information on the business model, market analysis, and team qualifications. Response times may vary, but a well-structured pitch is more likely to receive prompt attention.
In recent months, Rosetta Capital has continued to expand its portfolio, focusing on innovative companies in the life sciences sector. The firm has successfully exited several investments, including notable companies like Aprea Pharmaceutical and Immunocore.
Rosetta Capital remains active in the venture capital space, leveraging its 20 years of experience to identify and support promising healthcare startups.
What are Rosetta Capital's investment criteria?
Rosetta Capital focuses on the life sciences and medical device sectors, investing at seed, Series A, Series B, and growth equity stages. The firm seeks companies that demonstrate potential for significant impact in healthcare.
How can I pitch to Rosetta Capital?
Founders can reach out via email at info@rosettacapital.com. A well-prepared pitch deck should include details about the business model, market opportunity, and team background.
What makes Rosetta Capital different from other VCs?
Rosetta Capital specializes in direct secondary transactions, providing flexible liquidity solutions that cater to the unique needs of investors and corporations. Their extensive experience in managing complex transactions sets them apart.
What is the geographic scope of Rosetta Capital's investments?
The firm primarily invests in North America and Europe, allowing them to tap into diverse markets and opportunities in the life sciences sector.
What kind of support do portfolio companies receive?
Rosetta Capital engages with portfolio companies through follow-on financings and strategic management support, ensuring that they have the resources needed to succeed.
What is the typical check size for investments?
While specific check sizes are not disclosed, Rosetta Capital invests across various stages, indicating a flexible approach to funding based on the needs of the company.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.